Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
84 studies found for:    Open Studies | "Warfarin"
Show Display Options
Rank Status Study
21 Recruiting Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin
Condition: Hypoprothrombinemia
Interventions: Other: Warfarin adjustment using the Fearon algorithm;   Other: Warfarin adjustment using standard dosing
22 Not yet recruiting The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin
Condition: Blood Coagulation Disorders
Intervention: Drug: Voltaren ophtha 0.1%
23 Unknown  Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial
Condition: Anticoagulation
Interventions: Drug: warfarin;   Drug: Warfarin
24 Recruiting Comparison Between Thoracoscopic Left Atrial Appendage Excision and Warfarin for the Secondary Prevention of Stroke in Patients With AF
Conditions: Atrial Fibrillation;   Stroke;   Systemic Embolism
Interventions: Procedure: Thoracoscopic Left Atrial Appendage Excision;   Drug: Warfarin
25 Recruiting A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors
Condition: ALK-positive Advanced Tumors
Interventions: Drug: ceritinib;   Drug: warfarin;   Drug: midazolam
26 Recruiting Excessive Warfarin Anticoagulation - Causes and Consequences
Condition: Anticoagulation
27 Recruiting Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
Condition: Atherosclerosis
Interventions: Drug: rivaroxaban;   Drug: Warfarin
28 Unknown  Determinants of Warfarin Metabolism
Condition: Healthy
Interventions: Drug: Warfarin;   Drug: Phenytoin
29 Unknown  Genetic Determinants of Warfarin Anticoagulation Effect
Conditions: Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation
Intervention: Drug: Warfarin
30 Recruiting Genotype-guided Warfarin Individualized Treatment
Conditions: Atrial Fibrillation;   Deep Venous Thrombosis
Interventions: Behavioral: Genotype-guided dosing algorithm for warfarin;   Behavioral: Standard initiation dose for warfarin
31 Recruiting Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
Conditions: Coronary Artery Bypass Grafting;   Postoperative Atrial Fibrilation;   Stroke;   Systemic Embolism;   Deep Venous Thrombosis
Interventions: Drug: Apixaban;   Drug: Warfarin
32 Unknown  Pharmacogenetic Study of Warfarin Dose-Response: a Prospective Trial
Condition: Cardiovascular Diseases
33 Not yet recruiting Model-based Versus Traditional Warfarin Dosing in Children
Condition: Congenital Heart Defects
Interventions: Device: Warfarin Dosing Aid;   Other: Standard Practice
34 Recruiting Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
Condition: Atrial Fibrillation
Interventions: Genetic: Pharmacogenetic anticoagulation;   Drug: Traditional anticoagulation
35 Recruiting On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study
Condition: Thrombotic and Bleeding Events
Intervention: Device: On-X Aortic Heart Valve replacement
36 Unknown  Relationship Between Folic Acid and Warfarin Metabolism and Effect
Condition: Folic Acid Deficiency
Intervention: Drug: Folic acid
37 Recruiting Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention: Drug: warfarin
38 Recruiting Quality of Anticoagulation With Warfarin in Patient With Atrial Fibrillation for Secondary Stroke Prevention in Korea
Conditions: Atrial Fibrillation;   Stroke
39 Recruiting Blood Donation From Warfarin Users for the Development of POC INR Monitor
Conditions: Atrial Fibrillation;   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention: Procedure: Venepuncture
40 Recruiting Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.
Condition: Deep Venous Thrombosis
Interventions: Drug: Rivaroxaban;   Drug: Warfarin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years